Breaking News Instant updates and real-time market news.

SITO

Sito Mobile

$0.49

-0.01 (-2.00%)

16:16
11/26/19
11/26
16:16
11/26/19
16:16

Sito Mobile receives noncompliance letter from Nasdaq

Sito Mobile has received a notification letter from the Listing Qualifications Department of Nasdaq indicating that the company no longer meets the continued listing requirement related to the timely filing of its Form 10-Q for the period ended September 30. As a result of a delay in completing its Quarterly Report on Form 10-Q, the company no longer complies with the listing rules for continued listing. Under Nasdaq rules, the company now has 60 calendar days to submit a plan to regain compliance and if Nasdaq accepts SITO's plan, it can grant an exception of up to 180 calendar days from the filing's due date, or until May 18, 2020, to regain compliance. The company requires additional time to finalize preparation of its financial information for the three- and nine-months ended September 30 due to multiple extenuating circumstances including postponement of the annual meeting of stockholders, the timing of the receipt of comments from the Securities and Exchange Commission regarding submitted proxy materials and certain impacts associated with restructuring efforts that have been implemented. In the event the company does not regain compliance prior to the expiration of the compliance period or does not qualify for the second compliance period in respect of Rule 5450, the company will receive written notification that its securities are subject to delisting from Nasdaq. At that time, the company may appeal the delisting determination to a hearing's panel.

SITO Sito Mobile
$0.49

-0.01 (-2.00%)

04/02/19
CHLM
04/02/19
NO CHANGE
CHLM
Sito Mobile may be at 'inflection point,' says Craig-Hallum
Craig-Hallum analyst Mike Malouf reiterated a Buy rating and $3 price target on SITO Mobile, which is on the firm's Alpha Select List. The analyst noted that the company's strategy of pursuing larger, multi-million dollar, multi-year contracts has taken "way longer than investors had anticipated," but, with its recently awarded $10M contract, SITO may be at an "inflection point," and the impact for 2019 and into 2020 could be significant.
05/16/19
LSCM
05/16/19
DOWNGRADE
LSCM
Hold
Sito Mobile downgraded to Hold from Buy at Lake Street
05/16/19
LSCM
05/16/19
DOWNGRADE
Target $1.5
LSCM
Hold
Sito Mobile downgraded to Hold from Buy at Lake Street
Lake Street analyst Mark Argento downgraded Sito Mobile to Hold from Buy and lowered his price target for the shares to $1.50 from $4. Following the company's "big" Q1 miss, the analyst sees uncertainly around Sito Mobile's new product strategy and liquidity concerns in the near term. While the company's geo location data and advertising relationships remain valuable assets, the stock will likely remain in "show-me territory" pending execution by management, Argento tells investors in a research note.
05/16/19
05/16/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Occidental Petroleum (OXY) downgraded to Hold from Buy at Argus with analyst Bill Selesky citing its confirmed purchase of Anadarko Petroleum (APC) for $76 per share and saying the company is overpaying for the assets with a bid well above that of Chevron's (CVX) $65 per share offer. 2. Nomura (NMR) downgraded to Sell from Neutral at Citi with analyst Koichi Niwa saying he sees a "grim" earnings environment for Nomura's domestic retail division and fixed income business. 3. Sito Mobile (SITO) downgraded to Hold from Buy at Lake Street with analyst Mark Argento citing the company's "big" Q1 miss and said he sees uncertainty around Sito Mobile's new product strategy and liquidity concerns in the near term. 4. The Stars Group (TSG) downgraded to Hold from Buy at Desjardins. 5. Roan Resources (ROAN) downgraded to In-Line from Outperform at Imperial Capital with analyst Irene Haas saying the company's Q1 earnings missed expectations due to well performance, ethane rejection, and weak NGL prices. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BKH

Black Hills

$76.66

0.01 (0.01%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Black Hills utilities receive approval to upsize Renewable Ready program »

Black Hills announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRIM

Primoris

$21.92

0.3 (1.39%)

18:02
12/05/19
12/05
18:02
12/05/19
18:02
Hot Stocks
Primoris awarded two pipeline contracts for over $45M »

Primoris Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$35.94

-0.09 (-0.25%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
LeMaitre CFO sells 121K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLBK

Columbia Financial

$16.33

-0.24 (-1.45%)

18:01
12/05/19
12/05
18:01
12/05/19
18:01
Hot Stocks
Columbia Financial expands stock buyback to acquire additional 3M shares »

Columbia Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXS

Axis Capital

$58.42

0.31 (0.53%)

17:49
12/05/19
12/05
17:49
12/05/19
17:49
Hot Stocks
Axis Capital increases quarterly dividend 2.5% to 41c per share »

Axis Capital has declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

PZZA

Papa John's

$59.67

-0.53 (-0.88%)

17:48
12/05/19
12/05
17:48
12/05/19
17:48
Periodicals
Former Papa John's CEO files suit against ad firm, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 18

    Dec

THG

Hanover Insurance

$133.80

0.52 (0.39%)

17:47
12/05/19
12/05
17:47
12/05/19
17:47
Hot Stocks
Hanover Insurance raises dividend to 65c/shr, announces $2.50 special dividend »

The Hanover Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

BHVN

Biohaven Pharmaceutical

$53.79

-0.235 (-0.44%)

17:46
12/05/19
12/05
17:46
12/05/19
17:46
Hot Stocks
Biohaven Pharmaceutical issued patent relating to troriluzole »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$15.32

-0.48 (-3.04%)

17:45
12/05/19
12/05
17:45
12/05/19
17:45
Upgrade
Morgan Stanley upgrades Epizyme to Overweight ahead of lymphoma data »

Morgan Stanley analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

  • 18

    Dec

  • 23

    Jan

THG

Hanover Insurance

$133.80

0.52 (0.39%)

17:44
12/05/19
12/05
17:44
12/05/19
17:44
Hot Stocks
Hanover Insurance announces $150M accelerated buyback »

The Hanover Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MAS

Masco

$46.01

0.445 (0.98%)

17:35
12/05/19
12/05
17:35
12/05/19
17:35
Hot Stocks
Masco CFO sells 20K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$195.52

-1.13 (-0.57%)

17:31
12/05/19
12/05
17:31
12/05/19
17:31
Hot Stocks
Cigna's Foss acquires over 10,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 06

    Feb

GD

General Dynamics

$182.38

4.26 (2.39%)

17:30
12/05/19
12/05
17:30
12/05/19
17:30
Hot Stocks
General Dynamics awarded $145.75M Navy contract modification »

General Dynamics was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$69.51

-0.465 (-0.66%)

17:28
12/05/19
12/05
17:28
12/05/19
17:28
Hot Stocks
DocuSign up 8.5% to $75.38 after Q3 results beat estimates »

The company also raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 09

    Dec

  • 16

    Dec

DASTY

Dassault Systemes

$0.00

(0.00%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Initiation
Dassault Systemes initiated  »

Dassault Systemes resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULTA

Ulta Beauty

$236.09

-3.27 (-1.37%)

17:24
12/05/19
12/05
17:24
12/05/19
17:24
Hot Stocks
Ulta Beauty up 10% to $259.20 after Q3 profit beat estimates »

The company also narrowed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

AUMN

Golden Minerals

$0.30

0.0089 (3.07%)

17:21
12/05/19
12/05
17:21
12/05/19
17:21
Syndicate
Breaking Syndicate news story on Golden Minerals »

Golden Minerals files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YEXT

Yext

$16.62

0.065 (0.39%)

17:18
12/05/19
12/05
17:18
12/05/19
17:18
Hot Stocks
Breaking Hot Stocks news story on Yext »

Yext down 21% to $13.00…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

FIZZ

National Beverage

$48.28

-1.16 (-2.35%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Earnings
National Beverage reports Q2 EPS 70c, consensus 68c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:16
12/05/19
12/05
17:16
12/05/19
17:16
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$34.49

1.58 (4.80%)

17:15
12/05/19
12/05
17:15
12/05/19
17:15
Upgrade
Huazhu Group rating change  »

Huazhu Group upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONDS

Ondas Holdings

$0.00

(0.00%)

17:12
12/05/19
12/05
17:12
12/05/19
17:12
Syndicate
Breaking Syndicate news story on Ondas Holdings »

Ondas Holdings files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GH

Guardant Health

$73.57

-1.43 (-1.91%)

17:11
12/05/19
12/05
17:11
12/05/19
17:11
Hot Stocks
Guardant Health Chief Medical Officer Richard Lanman to retire »

On December 2, Richard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$44.13

0.1 (0.23%)

17:10
12/05/19
12/05
17:10
12/05/19
17:10
Hot Stocks
Douglas Emmett raises quarterly dividend by 8% to 28c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AXSM

Axsome Therapeutics

$43.27

-4.17 (-8.79%)

17:06
12/05/19
12/05
17:06
12/05/19
17:06
Syndicate
Breaking Syndicate news story on Axsome Therapeutics »

Axsome Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.